US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 25.460
- -1.470-5.46%
Close Jul 18 16:00 ET
- 25.500
- +0.040+0.16%
Post 17:34 ET
2.10BMarket Cap-15912P/E (TTM)
27.470High25.410Low1.76MVolume26.840Open26.930Pre Close45.72MTurnover2.30%Turnover RatioLossP/E (Static)82.31MShares49.50052wk High2.29P/B1.95BFloat Cap16.95052wk Low--Dividend TTM76.56MShs Float138.522Historical High--Div YieldTTM7.65%Amplitude13.000Historical Low25.976Avg Price1Lot Size
Beam Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -69.39%7.41M | 520.01%377.71M | 1,478.04%316.19M | 8.82%17.19M | 20.80%20.12M | 187.10%24.21M | 17.51%60.92M | -60.76%20.04M | 1,970.64%15.8M | 277,433.33%16.65M |
| Operating revenue | -69.39%7.41M | 520.01%377.71M | 1,478.04%316.19M | 8.82%17.19M | 20.80%20.12M | 187.10%24.21M | 17.51%60.92M | -60.76%20.04M | 1,970.64%15.8M | 277,433.33%16.65M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.42%111.54M | 38.76%554.19M | 68.16%183.33M | 17.14%125.46M | 23.98%122.26M | 45.45%123.14M | -10.11%399.4M | -4.83%109.02M | 52.14%107.1M | 67.21%98.62M |
| Selling and administrative expenses | 13.77%26.72M | 33.04%116.81M | 90.72%43.26M | 16.48%25.41M | 2.47%24.66M | 22.04%23.49M | 53.45%87.81M | 27.62%22.68M | 38.30%21.82M | 79.53%24.06M |
| -General and administrative expense | 13.77%26.72M | 33.04%116.81M | 90.72%43.26M | 16.48%25.41M | 2.47%24.66M | 22.04%23.49M | 53.45%87.81M | 27.62%22.68M | 38.30%21.82M | 79.53%24.06M |
| Research and development costs | -14.88%84.82M | 40.37%437.38M | 62.24%140.08M | 17.31%100.05M | 30.92%97.61M | 52.34%99.65M | -19.50%311.59M | -10.79%86.34M | 56.14%85.29M | 63.58%74.56M |
| Operating profit | -5.26%-104.13M | 47.86%-176.49M | 249.30%132.86M | -18.58%-108.27M | -24.62%-102.15M | -29.78%-98.93M | 13.76%-338.48M | -40.17%-88.99M | -31.12%-91.3M | -38.99%-81.97M |
| Net non-operating interest income expense | 18.95%11.85M | 205.13%46.68M | 58.51%12.06M | 154.88%12.7M | 480.24%11.95M | 1,446.74%9.96M | 170,066.67%15.3M | 13,994.44%7.61M | 55,255.56%4.98M | 4,061.54%2.06M |
| Non-operating interest income | ---- | ---- | ---- | 154.88%12.7M | ---- | ---- | ---- | ---- | --4.98M | ---- |
| Total other finance cost | -18.95%-11.85M | -205.13%-46.68M | ---- | ---- | -480.24%-11.95M | -1,446.74%-9.96M | -170,066.67%-15.3M | ---- | ---- | -4,061.54%-2.06M |
| Other net income (expense) | 14.77%-6.39M | -102.15%-1.35M | -101.72%-759K | -111.15%-519K | -6.75%7.42M | -217.68%-7.49M | 188.53%63M | 3,547.53%44.03M | -88.78%4.66M | 146.18%7.96M |
| Gain on sale of security | 13.12%-6.25M | -125.15%-11.09M | -110.67%-2.62M | -217.90%-6.52M | -35.02%5.25M | -221.67%-7.2M | 164.23%44.1M | 685.24%24.58M | -82.10%5.53M | 148.99%8.08M |
| Special income (charges) | 55.07%-133K | -48.48%9.74M | -90.42%1.86M | 785.94%6M | 1,909.17%2.17M | -165.49%-296K | 267.35%18.9M | 541.28%19.45M | -108.26%-875K | 83.81%-120K |
| -Less：Restructuring and merger&acquisition | -55.07%133K | 48.48%-9.74M | 90.42%-1.86M | -785.94%-6M | -1,909.17%-2.17M | 165.49%296K | -267.35%-18.9M | -541.28%-19.45M | 108.26%875K | -83.81%120K |
| Income before tax | -2.29%-98.67M | 49.59%-131.16M | 485.99%144.16M | -17.66%-96.09M | -15.05%-82.78M | -39.36%-96.46M | 29.80%-260.18M | 42.28%-37.35M | -190.44%-81.67M | 5.64%-71.95M |
| Income tax | -59.94%1.37M | 36.60%1.37M | 0 | 3.41M | 1M | 2.41M | ||||
| Earnings from equity interest net of tax | ---- | --0 | --0 | --0 | ---- | ---- | ---25.5M | --0 | ---25.5M | ---- |
| Net income | -2.29%-98.67M | 54.16%-132.53M | 472.36%142.8M | 12.31%-96.09M | -15.05%-82.78M | -39.36%-96.46M | 22.00%-289.09M | 40.73%-38.35M | -289.70%-109.58M | 5.64%-71.95M |
| Net income continuous Operations | -2.29%-98.67M | 54.16%-132.53M | 472.36%142.8M | 12.31%-96.09M | -15.05%-82.78M | -39.36%-96.46M | 22.00%-289.09M | 40.73%-38.35M | -289.70%-109.58M | 5.64%-71.95M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -2.29%-98.67M | 54.16%-132.53M | 472.36%142.8M | 12.31%-96.09M | -15.05%-82.78M | -39.36%-96.46M | 22.00%-289.09M | 40.73%-38.35M | -289.70%-109.58M | 5.64%-71.95M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -2.29%-98.67M | 54.16%-132.53M | 472.36%142.8M | 12.31%-96.09M | -15.05%-82.78M | -39.36%-96.46M | 22.00%-289.09M | 40.73%-38.35M | -289.70%-109.58M | 5.64%-71.95M |
| Basic earnings per share | 9.02%-1.21 | 58.35%-1.72 | 427.78%1.77 | 21.79%-1.22 | -5.88%-1.08 | -31.68%-1.33 | 28.42%-4.13 | 43.16%-0.54 | -271.43%-1.56 | 17.07%-1.02 |
| Diluted earnings per share | 9.02%-1.21 | 58.35%-1.72 | 420.37%1.73 | 21.79%-1.22 | -5.88%-1.08 | -31.68%-1.33 | 28.42%-4.13 | 43.16%-0.54 | -271.43%-1.56 | 17.07%-1.02 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
